logo

For the Inventor, By the Inventor

Kawasaki, Japan

Takuji Kawashima

This inventor holds 6 USPTO granted patents. Top assignee: Morinaga Milk Industry Co., Ltd.. Active years: 1986-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takuji Kawashima. Retrieved from https://idiyas.com/inventor/takuji-kawashima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal6 out of 185 
 
Morinaga Milk Industry Co., Ltd.
 patents

Years Active: 1986-1994

Loading Chart...
6 patents (USPTO):Explore Patents
1. 5288487 - Human monocyte-macrophage-CSF preparations (1994-02-22),
2. 5095005 - Polypeptide and antibacterial preparations containing the same (1992-03-10),
3. 4797389 - Substance having an anti-infective activity (1989-01-10),
4. 4792549 - Composition of amino acids (1988-12-20),
5. 4645667 - Antitumor agent and process for manufacturing said agent (1987-02-24),
6. 4588595 - Culture containing a viable cell mass of Bifidobacteria and lactic acid (1986-05-13),

Title: Takuji Kawashima: Innovator in Biopharmaceuticals

Introduction

Takuji Kawashima is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapeutic preparations. With a total of 6 patents to his name, Kawashima's work has had a notable impact on medical treatments.

Latest Patents

Kawashima's latest patents include groundbreaking advancements in human monocyte-macrophage-CSF preparations. His work on human M-CSF preparations and recombinant human M-CSF preparations targets conditions such as myelodysplastic syndrome, malignant tumors, and hyperlipidemia. Additionally, he has developed auxiliary therapeutic preparations designed to be used alongside platinum-complex anticancer treatments. Another significant patent involves a new polypeptide derived from royal jelly, which exhibits a specific amino acid sequence and heat stability. This polypeptide is effective in antibacterial preparations against Gram-positive bacteria and can withstand standard sterilization procedures.

Career Highlights

Kawashima is associated with Morinaga Milk Industry Co., Ltd., where he has been instrumental in advancing research and development in biopharmaceuticals. His innovative approaches have led to the creation of effective therapeutic solutions that address critical health issues.

Collaborations

Kawashima has collaborated with notable colleagues, including Shigeo Okonogi and Tomoko Yaeshima. Their combined expertise has contributed to the success of various projects and patents.

Conclusion

Takuji Kawashima's contributions to biopharmaceuticals exemplify the importance of innovation in medical science. His patents reflect a commitment to improving health outcomes through advanced therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…